Cargando…

An IL6-correlated signature in serous epithelial ovarian cancer associates with growth factor response

BACKGROUND: Epithelial ovarian cancer (EOC) is one of the most lethal gynecological cancers; the majority of EOC is the serous histotype and diagnosed at advanced stage. IL6 is the cytokine that has been found most frequently associated with carcinogenesis and progression of serous EOCs. IL6 is a gr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pinciroli, Patrizia, Alberti, Chiara, Sensi, Marialuisa, Canevari, Silvana, Tomassetti, Antonella
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3728068/ https://www.ncbi.nlm.nih.gov/pubmed/23889749 http://dx.doi.org/10.1186/1471-2164-14-508

Ejemplares similares

Axl in ovarian cancer: a step forward for clinical breakthrough?
por: Sensi, Marialuisa, et al.
Publicado: (2016)

Novel Axl-driven signaling pathway and molecular signature characterize high-grade ovarian cancer patients with poor clinical outcome
por: Rea, Katia, et al.
Publicado: (2015)

A melanoma subtype with intrinsic resistance to BRAF inhibition identified by receptor tyrosine kinases gene-driven classification
por: Dugo, Matteo, et al.
Publicado: (2015)

The genomics of desmoplastic small round cell tumor reveals the deregulation of genes related to DNA damage response, epithelial–mesenchymal transition, and immune response
por: Devecchi, Andrea, et al.
Publicado: (2018)

Clinicopathological Impact of ABCC1/MRP1 and ABCC4/MRP4 in Epithelial Ovarian Carcinoma
por: Bagnoli, Marina, et al.
Publicado: (2013)

EGFR/MEK/ERK/CDK5-dependent integrin-independent FAK phosphorylated on serine 732 contributes to microtubule depolymerization and mitosis in tumor cells
por: Rea, K, et al.
Publicado: (2013)

Focal Recurrent Copy Number Alterations Characterize Disease Relapse in High Grade Serous Ovarian Cancer Patients with Good Clinical Prognosis: A Pilot Study
por: Dugo, Matteo, et al.
Publicado: (2019)

Integrated Ligand-Receptor Bioinformatic and In Vitro Functional Analysis Identifies Active TGFA/EGFR Signaling Loop in Papillary Thyroid Carcinomas
por: Degl'Innocenti, Debora, et al.
Publicado: (2010)

Prevalence of viral DNA in high-grade serous epithelial ovarian cancer and correlation with clinical outcomes
por: Robertson, Sharon E., et al.
Publicado: (2023)

Classification of High-Grade Serous Ovarian Carcinoma by Epithelial-to-Mesenchymal Transition Signature and Homologous Recombination Repair Genes
por: Sohn, Min-Hwan, et al.
Publicado: (2021)

Expression signatures of TP53 mutations in serous ovarian cancers
por: Bernardini, Marcus Q, et al.
Publicado: (2010)

Role of perigastric arcade removal in serous epithelial ovarian cancers
por: Kulkarni, Rohini Vinayak, et al.
Publicado: (2023)

Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer
por: Kan, Casina WS, et al.
Publicado: (2012)

Transcriptome-based signature predicts the effect of taxol in serous ovarian cancer
por: Hou, Shunyu, et al.
Publicado: (2018)

Prognostic gene expression signature for high-grade serous ovarian cancer
por: Millstein, J., et al.
Publicado: (2020)

Epithelial/mesenchymal heterogeneity of high‐grade serous ovarian carcinoma samples correlates with miRNA let‐7 levels and predicts tumor growth and metastasis
por: Chirshev, Evgeny, et al.
Publicado: (2020)

Guidance of Signaling Activations by Cadherins and Integrins in Epithelial Ovarian Cancer Cells
por: Roggiani, Francesca, et al.
Publicado: (2016)

Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma
por: Ducie, Jennifer, et al.
Publicado: (2017)

Characterization of three new serous epithelial ovarian cancer cell lines
por: Ouellet, Véronique, et al.
Publicado: (2008)

Upregulated CDK16 Expression in Serous Epithelial Ovarian Cancer Cells
por: Zhou, Qi, et al.
Publicado: (2015)

SOX11 and Epithelial-Mesenchymal Transition in Metastatic Serous Ovarian Cancer
por: Psilopatis, Iason, et al.
Publicado: (2023)

Simultaneous E-cadherin and PLEKHA7 expression negatively affects E-cadherin/EGFR mediated ovarian cancer cell growth
por: Rea, Katia, et al.
Publicado: (2018)

Genomic Rearrangement Signatures and Clinical Outcomes in High-Grade Serous Ovarian Cancer
por: Hillman, R Tyler, et al.
Publicado: (2017)

Development of a Novel Autophagy-related Prognostic Signature for Serous Ovarian Cancer
por: An, Yuanyuan, et al.
Publicado: (2018)

An Immune-Related Gene-Based Signature as Prognostic Tool in Ovarian Serous Cystadenocarcinoma
por: Shi, Fengjuan, et al.
Publicado: (2021)

Association of Copy Number Variation Signature and Survival in Patients With Serous Ovarian Cancer
por: Graf, Ryon P., et al.
Publicado: (2021)

Detection of TP53 Clonal Variants in Papanicolaou Test Samples Collected up to 6 Years Prior to High-Grade Serous Epithelial Ovarian Cancer Diagnosis
por: Paracchini, Lara, et al.
Publicado: (2020)

MRI appearance of ovarian serous borderline tumors of the micropapillary type compared to that of typical ovarian serous borderline tumors: radiologic-pathologic correlation
por: Nakai, Go, et al.
Publicado: (2018)

One-Carbon Metabolism: Biological Players in Epithelial Ovarian Cancer
por: Rizzo, Andrea, et al.
Publicado: (2018)

Peritoneal tumor spread in serous ovarian cancer-epithelial mesenchymal status and outcome
por: Auer, Katharina, et al.
Publicado: (2015)

Prognostic significance of normal-sized ovary in advanced serous epithelial ovarian cancer
por: Paik, E Sun, et al.
Publicado: (2018)

Prognostic Significance of HE4 Tissue Expression in Serous Epithelial Ovarian Carcinoma
por: Sethi, Ankita, et al.
Publicado: (2022)

HDAC6 Degradation Inhibits the Growth of High-Grade Serous Ovarian Cancer Cells
por: Ali, Ahlam, et al.
Publicado: (2020)

Combining TNFR2-Expressing Tregs and IL-6 as Superior Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Masses
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2023)

A Five-Gene Expression Signature Predicts Clinical Outcome of Ovarian Serous Cystadenocarcinoma
por: Liu, Li-Wei, et al.
Publicado: (2016)

An immune-related gene pairs signature predicts overall survival in serous ovarian carcinoma
por: Zhang, Liuyan, et al.
Publicado: (2019)

Clinical Interest of Combining Transcriptomic and Genomic Signatures in High-Grade Serous Ovarian Cancer
por: Kieffer, Yann, et al.
Publicado: (2020)

Development of a novel transcription factors-related prognostic signature for serous ovarian cancer
por: Li, He, et al.
Publicado: (2021)

Stem Cell-Associated Signatures Help to Predict Diagnosis and Prognosis in Ovarian Serous Cystadenocarcinoma
por: Li, Li, et al.
Publicado: (2023)

Correlation of FOXC1 protein with clinicopathological features in serous ovarian tumors
por: WANG, LU-YING, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l8m226284hg5c5mhnk2pqiunvj